| | |
Reuters 01:31 PM | November 17,2009
Novartis said data from about 4,000 individuals suggested that half a dose of its US-approved unadjuvanted H1N1 vaccine met immune criteria in adults and the elderly
|
|
Reuters 02:11 PM | November 04,2009
Novartis said on Wednesday the acquisition was part of a strategic initiative to build a vaccines industry leader in China and expand its limited presence in this booming market segment
|
|
C.H. Unnikrishan 12:08 AM | October 30,2009
Sales grew 4.6% from the year-ago period to Rs161.5 crore
|
|
C.H. Unnikrishnan 11:31 PM | October 28,2009
Aventis Pharma, an India-listed unit of French drug maker Sanofi-Aventis SA, is locked in a tussle over the vaccine with Novartis Healthcare Ltd, the Indian subsidiary of Switzerland’s Novartis AG
|
|
AFP 12:45 PM | October 22,2009
The drugmaker raised its full-year sales forecast, as its new swine flu pandemic vaccines alone are expected to rake in up to 700 million dollar worth of revenues in the fourth quarter
|
|
Sam Cage / Reuters 02:33 PM | October 08,2009
The drug already has solid mid-stage data which show it to be equal or superior to Pfizer Inc’s Zyvox, said Kepler Capital Markets analyst Tero Weckroth
|
|
C.H. Unnikrishnan 11:21 PM | October 07,2009
Move to assist the judiciary, which is not yet fully conversant with the technical aspects of patent cases
|
|
Ben Hirschler / Reuters 03:06 PM | October 06,2009
149 million doses ordered since August, total now 440 million; implies booked orders to date worth around $3.5 billion; discussions continue with governments for further supplies
|
|
Khushboo Narayan and C.H. Unnikrishnan 09:12 PM | October 01,2009
Novartis faces charges of not paying tax on pending superannuation fund deductions in 2001-02
|
|
Reuters 11:23 AM | September 24,2009
Japan’s benchmark Nikkei index jumped 1.7% after a three-day holiday break, but the rise reflected gains made in the rest of the region at the start of the week
|
|
06:29 PM | September 14,2009
Companies may be replacing IPOs with something better; Fortis plans to unveil its Rs1,000 crore rights issues by October; Dr Reddy’s Laboratories launches generic version of a Novartis drug in the US
|
|
Manish Ranjan 09:42 PM | September 11,2009
The apex court sought replies from the commerce ministry, the comptroller general of patents, the Cancer Patient Aid Association and the four pharma firms that state their objections on why the patent should not be granted to Novartis
|
|
Sam Cage and Lucy Hornby / Reuters 11:41 PM | September 03,2009
Officials are concerned that supplies of vaccine will prove tight but a need to vaccinate people only once instead of twice would stretch out stocks substantially
|
|
C.H. Unnikrishnan 10:28 PM | August 24,2009
The company is also in talks with a clutch of research-based drug companies in India to license potential technologies for products that can compensate it for the lost market slot
|
|
Reuters 09:06 AM | August 06,2009
The swine flu vaccine, to be sold under the brand name Celvapan, is made using Baxter’s cell culture process, which is designed to be faster than traditional vaccine production methods
|
|